The engineering of ROR1-CAR-T cells with synNotch receptors that are specific for EpCAM or B7-H3, expressed on ROR1+ tumor cells but not on ROR1+ stromal cells, can induce ROR1 expression selectively within the tumor, thus sparing normal tissues (119). Here, CD276 is linked to neoplasm.